As of 2025-11-05, the Relative Valuation of Impel Neuropharma Inc (IMPL) is (327.35) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.24 USD, the upside of Impel Neuropharma Inc based on Relative Valuation is -135874.5%.
The range of the Relative Valuation is (333.01) - (332.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 14.8x | 14.6x |
| Forward P/E multiples | 13.1x - 14.4x | 13.8x |
| Fair Price | (333.01) - (332.09) | (327.35) |
| Upside | -138221.3% - -137838.1% | -135874.5% |
| Date | P/E |